Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Chemotherapy Relative Dose Intensity, Overall Survival, and Hematologic Toxicity in Solid-Tumor Cancer Patients: A Literature Review and Meta-Analysis

Lauren C Bylsma, MPH, Carrie M Nielson, PhD, Jon P Fryzek, Hossam A Saad, MD, Jeffrey Crawford, MD

Blood (2020) 136 (Supplement 1): 32–33.

https://doi.org/10.1182/blood-2020-139279

Published: 2020

Journal Articles

Epidemiology and Management of Immune Thrombocytopenia in Adult Patients in Algeria: A Non-Interventional, Longitudinal, Nationwide Estimation Study

Mohamed-Amine Bekadja, Mohamed Bradai, Hocine Ait Ali, Selma Hamdi, Nadia Boudjerra, Mahdia Hocine Saidi, Fatiha Grifi, Djamel Saidi, Naima Mesli, Zahia Zouaoui, Nourredine Lakhdari, Nemra Mehalhal, Noureddine Sidimansour, Ryma Tiaiba, Sarah Lakehal, Hossam A Saad, MD

Blood (2020) 136 (Supplement 1): 3–4.

https://doi.org/10.1182/blood-2020-139569

Published: 2020

Journal Articles

Treatment Patterns and Bleeding Events Among Patients with Immune Thrombocytopenia Based on Duration of Corticosteroid Treatment

Mark D. Hatfield, PhD, Janna Manjelievskaia, PhD MPH, Kristin A. Evans, PhD, Philip K. Chan, PhD MS, Neel Shah, BPharm, PhD, Hossam A Saad, MD

Blood (2020) 136 (Supplement 1): 40–41.

https://doi.org/10.1182/blood-2020-141457

Published: 2020

Journal Articles

Hematopoietic Cell Transplant Co-Morbidity Index (HCTCI) and Multiple Myeloma (MM) Survival After Autologous Hematopoietic Cell Transplantation (AHCT)

Anuj Mahindra, Ayman A Saad, MD, Mei-Jie Zhang, PhD, Xiaobo Zhong, MS, Angela Dispenzieri, MD, Amrita Krishnan, MD, Sagar Lonial, MD, Marcelo C Pasquini, MD, MS, Parameswaran Hari, MBBS, MD, MRCP

Blood (2012) 120 (21): 4217.

https://doi.org/10.1182/blood.V120.21.4217.4217

Published: 2012

Journal Articles

Second Autologous Transplants for Multiple Myeloma (MM) Relapse After a Prior Autologous Transplant (AHCT) – a Report From the Center for International Blood and Marrow Transplant Research (CIBMTR)

Ayman A Saad, MD, David H. Vesole, MD, PhD, Jennifer Le-Rademacher, PhD, Xiaobo Zhong, MS, Angela Dispenzieri, MD, Sagar Lonial, MD, Gustavo A. Milone, MD, Parameswaran Hari, MBBS, MD, MRCP

Blood (2011) 118 (21): 504.

https://doi.org/10.1182/blood.V118.21.504.504

Published: 2011

Journal Articles

Patterns of Myeloma (MM) Progression After Autologous Transplant (AHCT) – Biochemical Progression Vs. Clinical Relapse

Robert Frank Cornell, MD, Jonathan Thompson, MD, Leena Varkey Maramattom, MD, Mazie Froedtert Willms & Sue Froedtert Cancer Fellow, Veerpal Singh, MD, Ayman A Saad, MD, Jeanne Palmer, MD, Mathew Thomas, Parameswaran Hari, MBBS, MD, MRCP

Blood (2011) 118 (21): 5097.

https://doi.org/10.1182/blood.V118.21.5097.5097

Published: 2011

Journal Articles

The Impact of Co-Morbidities on the Outcome of Autologous Stem Cell Transplantation for Multiple Myeloma

Ayman A Saad, MD, Marc Sala, MD, Niravkumar A. Naik, MD, Parameswaran Hari, MBBS, MD, MRCP

Blood (2011) 118 (21): 4511.

https://doi.org/10.1182/blood.V118.21.4511.4511

Published: 2011

Journal Articles

Bortezomib Based Therapy for Newly Diagnosed Patients with Advanced Multisystem Light Chain Amyloidosis (AL)

Leena Varkey Maramattom, MD, Mazie Froedtert Willms & Sue Froedtert Cancer Fellow, Veerpal Singh, MD, Robert Frank Cornell, MD, Jasleen K Randhawa, MD, Mathew Thomas, Ayman A Saad, MD, Jeanne Palmer, MD, Parameswaran Hari, MBBS, MD, MRCP

Blood (2011) 118 (21): 1880.

https://doi.org/10.1182/blood.V118.21.1880.1880

Published: 2011

Journal Articles

Disruption of the Crosstalk CXCL12/CXCR4 Chemotactic Pathway To Enhance Melphalan-Induced Apoptosis in Multiple Myeloma Cell Lines.

Ayman A. Saad, MD, James Fortney, BS, Lin Wang, Ph D, Heather O’Leary, BS, Laura Gibson, PHD, Solveig Ericson, MD, PhD

Blood (2006) 108 (11): 3445.

https://doi.org/10.1182/blood.V108.11.3445.3445

Published: 2006

Journal Articles

Late Onset, Acute Severe Neutropenia in Patients Treated with Rituximab for B-Cell Lymphoproliferation.

Philippe Solal-Celigny, md, F. Morschhauser, md, O. Tournilhac, md, C. Foussard, md, O. Fitoussi, md, A. Lillo-Le Louet, md, P. Brice, md, T. Lamy, md, H. Tilly, md, E. Gyan, md, Ph. Agape, md, E. Suc, md, A. Saad, md, A. Devidas, md, M. Blanc, md, A. Le Rol, md, P. Galanaud, md, J. Y. Muller, md, E. Voog, md

Blood (2004) 104 (11): 4607.

https://doi.org/10.1182/blood.V104.11.4607.4607

Published: 2004

NARROW

Chemotherapy Relative Dose Intensity, Overall Survival, and Hematologic Toxicity in Solid-Tumor Cancer Patients: A Literature Review and Meta-Analysis

Epidemiology and Management of Immune Thrombocytopenia in Adult Patients in Algeria: A Non-Interventional, Longitudinal, Nationwide Estimation Study

Treatment Patterns and Bleeding Events Among Patients with Immune Thrombocytopenia Based on Duration of Corticosteroid Treatment

Hematopoietic Cell Transplant Co-Morbidity Index (HCTCI) and Multiple Myeloma (MM) Survival After Autologous Hematopoietic Cell Transplantation (AHCT)

Second Autologous Transplants for Multiple Myeloma (MM) Relapse After a Prior Autologous Transplant (AHCT) – a Report From the Center for International Blood and Marrow Transplant Research (CIBMTR)

Patterns of Myeloma (MM) Progression After Autologous Transplant (AHCT) – Biochemical Progression Vs. Clinical Relapse

The Impact of Co-Morbidities on the Outcome of Autologous Stem Cell Transplantation for Multiple Myeloma

Bortezomib Based Therapy for Newly Diagnosed Patients with Advanced Multisystem Light Chain Amyloidosis (AL)

Disruption of the Crosstalk CXCL12/CXCR4 Chemotactic Pathway To Enhance Melphalan-Induced Apoptosis in Multiple Myeloma Cell Lines.

Late Onset, Acute Severe Neutropenia in Patients Treated with Rituximab for B-Cell Lymphoproliferation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only